— medmix at a glance — Our key figures
Our key figures
Our revenue increased by 30.2% (21.5% organically), back to pre-pandemic 2019 levels and closing the year with a record order backlog. We reached a profitability of 25.0% adjusted EBITDA margin. Free cash flow generation of CHF 55.6 million was an improvement of CHF 46.2 million over the previous year.
Share of revenue by market segment
2021
Key figures
|
millions of CHF |
|
2021 |
|
2020 |
|
Change in +/–% |
|
+/–% adjusted 1) |
|
+/–% organic 2) |
|
Revenue |
|
457.3 |
|
351.3 |
|
30.2 |
|
30.2 |
|
21.5 |
|
Gross profit |
|
181.2 |
|
121.1 |
|
49.7 |
|
|
|
|
|
Operating income (EBIT) |
|
59.9 |
|
18.1 |
|
231.2 |
|
|
|
|
|
EBITDA |
|
111.7 |
|
61.2 |
|
82.4 |
|
|
|
|
|
Adjusted EBITDA |
|
114.5 |
|
66.0 |
|
73.4 |
|
|
|
|
|
Adjusted EBITDA margin |
|
25.0% |
|
18.8% |
|
|
|
|
|
|
|
Net income attributable to shareholders of medmix Ltd |
|
44.0 |
|
9.6 |
|
357.4 |
|
|
|
|
|
Basic earnings per share (in CHF) |
|
1.07 |
|
0.28 |
|
281.5 |
|
|
|
|
|
Free cash flow (FCF) |
|
55.6 |
|
9.4 |
|
493.5 |
|
|
|
|
|
Net debt as of December 31 |
|
110.9 |
|
286.0 |
|
–61.2 |
|
|
|
|
|
Employees (number of full-time equivalents) as of December 31 |
|
2’036 |
|
1’849 |
|
10.1 |
|
|
|
|
1) Adjusted for currency effects.
2) Adjusted for acquisition and currency effects.
Our KEY Figures
revenue in 2021
adjusted EBITDA margin
free cash flow generated in 2021
Stock market information
|
|
|
2021 |
|
|
|
|
|
Registered share (in CHF) |
|
|
|
|
|
|
|
– high |
|
48.44 |
|
|
|
|
|
– low |
|
41.00 |
|
|
|
|
|
– year-end |
|
45.16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Market capitalization as of December 31 |
|
|
|
|
|
|
|
– number of shares issued |
|
41’262’370 |
|
|
|
|
|
– in millions of CHF |
|
1’863 |
|
|
|
|
|
– in percentage of equity |
|
349% |
|
|
|
|
|
|
|
|
|
|
|
|
|
P/E ratio as of December 31 |
|
42.2x |
|
|
|
|
|
Dividend yield as of December 31 |
|
1.1% |
|
|
|
|
Data per share
|
CHF |
|
2021 |
|
|
|
|
|
Net income attributable to a shareholder of medmix Ltd |
|
1.07 |
|
|
|
|
|
Equity attributable to a shareholder of medmix Ltd |
|
12.90 |
|
|
|
|
|
Ordinary dividend |
|
0.50 1) |
|
|
|
|
|
Payout ratio |
|
47% |
|
|
|
|
|
Average number of shares outstanding |
|
41’161’439 |
|
|
|
|
1) Proposal to the Annual General Meeting.
Shareholder structure as per December 31, 2021
|
Number of shares |
|
Number of shareholders |
|
Shareholding |
|
1–100 |
|
3’615 |
|
0.5% |
|
101–1’000 |
|
4’970 |
|
4.2% |
|
1’001–10’000 |
|
651 |
|
4.3% |
|
10’001–100’000 |
|
69 |
|
5.1% |
|
More than 100’000 |
|
19 |
|
52.7% |
|
Total registered shareholders and shares (excluding treasury shares medmix Ltd) |
|
9’324 |
|
66.8% |